Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave.
Children's Hospital, Neurology
Boston, MA 02115Phone+1 617-355-8735
Education & Training
University of Toronto Faculty of MedicineClass of 1990
Clinical Trials
- A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome Start of enrollment: 2022 Mar 04
Roles: Principal Investigator
- A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome Start of enrollment: 2021 Oct 28
Roles: Principal Investigator
- A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome Start of enrollment: 2021 Nov 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- 236 citationsAmerican clinical neurophysiology society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates: report of the A...Tammy N. Tsuchida, Courtney J. Wusthoff, Renée A. Shellhaas, Nicholas S. Abend, Cecil D. Hahn
Journal of Clinical Neurophysiology. 2013-04-01 - 139 citationsElectrographic seizures in pediatric ICU patients: Cohort study of risk factors and mortalityNicholas S. Abend, Daniel H. Arndt, Jessica L. Carpenter, Kevin E. Chapman, Karen M. Cornett
Neurology. 2013-07-23 - 40 citationsElectroencephalography monitoring in critically ill children: current practice and implications for future study designSarah M. Sanchez, Daniel H. Arndt, Jessica L. Carpenter, Kevin E. Chapman, Karen M. Cornett
Epilepsia. 2013-08-01
Press Mentions
Educational Initiatives for Electroencephalography in the Critical Care Setting: A Systematic Review and Meta-AnalysisMarch 11th, 2021
L'étude ELEKTRA De Phase 2 Évaluant Le Soticlestat (TAK-935/OV935) Atteint Son Critère Principal De Réduction De La Fréquence Des Crises Chez Les Enfants Atteints Du Syndrome De Dravet Ou Du Syndrome De Lennox-GastautAugust 26th, 2020- Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut SyndromeAugust 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
